Regal J F, Fraser D G, Anderson D E, Solem L E
Department of Pharmacology, University of Minnesota-Duluth 55812.
J Immunol. 1993 Apr 15;150(8 Pt 1):3496-505.
Our previous studies have demonstrated that activation of the C system with cobra venom factor (CVF) in a passively sensitized guinea pig results in an enhanced bronchoconstrictor response to Ag but not to other constrictor agents. Thus, our immediate goal was to determine the mechanism of the CVF-induced enhancement of the Ag-induced bronchoconstriction. Isolated airways from sensitized guinea pigs that had been treated with CVF responded normally to Ag. Because such a system lacks the normal circulating cell populations, we hypothesized that the CVF-induced enhancement of the Ag-induced bronchoconstriction was dependent on the presence of circulating white blood cells or platelets. Guinea pigs were depleted of circulating granulocytes, platelets, or both using specific antisera and the effect on the CVF-induced enhancement of the Ag-induced bronchoconstriction was determined. We found that CVF treatment did not result in an enhanced Ag-induced bronchoconstriction in guinea pigs depleted of either granulocytes or both granulocytes and platelets. However, the enhanced response was still apparent in guinea pigs depleted of just platelets. We investigated the effects of CVF itself and found that CVF treatment did not alter the number, or percentages, of different cell populations in the bronchoalveolar lavage, did not alter the protein or albumin content of the lavage fluid or the wet:dry ratio of the lung. In addition, CVF did not cause an increase in airway microvascular permeability as assessed by leakage of Evans blue. However, CVF did substantially increase granulocytes sequestered in the lung as measured by increased myeloperoxidase content. Thus, C activation by CVF results in an increase in neutrophils in the lung and an enhanced Ag-induced bronchoconstriction dependent on the presence of circulating granulocytes. These studies suggest that C activation and/or retention of granulocytes in the lung may be important in determining the severity of an Ag-induced bronchoconstriction.
我们之前的研究表明,在被动致敏的豚鼠中用眼镜蛇毒因子(CVF)激活补体系统会导致对变应原(Ag)的支气管收缩反应增强,但对其他收缩剂则无此作用。因此,我们的近期目标是确定CVF诱导的Ag诱导支气管收缩增强的机制。用CVF处理过的致敏豚鼠的离体气道对Ag反应正常。由于这样的系统缺乏正常循环的细胞群体,我们推测CVF诱导的Ag诱导支气管收缩增强依赖于循环白细胞或血小板的存在。使用特异性抗血清使豚鼠的循环粒细胞、血小板或两者均减少,并确定其对CVF诱导的Ag诱导支气管收缩增强的影响。我们发现,在粒细胞或粒细胞与血小板均减少的豚鼠中,CVF处理并未导致Ag诱导的支气管收缩增强。然而,在仅血小板减少的豚鼠中,增强反应仍然明显。我们研究了CVF本身的作用,发现CVF处理并未改变支气管肺泡灌洗中不同细胞群体的数量或百分比,未改变灌洗液的蛋白质或白蛋白含量或肺的湿重:干重比。此外,通过伊文思蓝渗漏评估,CVF并未导致气道微血管通透性增加。然而,通过髓过氧化物酶含量增加来衡量,CVF确实使肺中隔离的粒细胞大量增加。因此,CVF激活补体导致肺中中性粒细胞增加以及依赖于循环粒细胞存在的Ag诱导支气管收缩增强。这些研究表明,补体激活和/或肺中粒细胞的滞留可能在决定Ag诱导支气管收缩的严重程度方面很重要。